Stock Analiz

Immix Biopharma, Inc. (IMMX) stock forecast and price target

Price $7.84 · data as of November 13, 2026

12-month price target

Average target$23.80
Upside / downside+203.6%
Analysts8
ConsensusStrong buy
Low $17.40Average $23.80High $30.00

Gold marker: average target · white marker: today’s price ($7.84)

Analyst ratings

Strong buy 3Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.73+17.6%$0
Next fiscal year
ends December 31, 2027
$-0.94−28.0%$33M
Next quarter
ends December 31, 2026
$-0.18+35.7%$0
Quarter after
ends March 31, 2027
$-0.22−24.4%$0

Consensus of the analysts covering Immix Biopharma, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.

Frequently asked questions

What is the Immix Biopharma stock price target?

The average 12-month target from 8 analysts is $23.80, 203.6% above the current price of $7.84 Targets range from $17.40 to $30.00.

Is Immix Biopharma a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Immix Biopharma expected to earn?

Analysts expect EPS of $-0.73 for the fiscal year ending December 31, 2026 and $-0.94 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.